Optiscan Imaging Stock

Optiscan Imaging Forward P/E

The Forward P/E Ratio of Optiscan Imaging (OIL.AX) as of Sep 9, 2026 is -14.06. In the previous year, Forward P/E Ratio was -14.64 — a change of -3.98% (higher).

Forward P/E

-14.06

YoY

-3.98%

Last updated:

Forward P/E Ratio of Optiscan Imaging is 2026 -14.06 . Forward P/E Ratio of Optiscan Imaging was 2025 -14.64 . It decreases by -3.98% higher compared to the previous year.

The Optiscan Imaging Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
-43.61 AUD
Jan 1, 2019
-37.86 AUD
Jan 1, 2020
-50.27 AUD
Jan 1, 2021
-41.73 AUD
Jan 1, 2022
-20.97 AUD
Jan 1, 2023
-20.40 AUD
Jan 1, 2024
-14.64 AUD
Jan 1, 2025
-14.06 AUD
The Optiscan Imaging Forward P/E history
YEARForward P/EYoY
-14.06-3.98%
-14.64-28.20%
-20.40-2.72%
-20.97-49.76%
-41.73-16.99%
-50.27+32.78%
-37.86-13.17%
-43.61+44.59%
-30.16-54.57%
-66.38+4.36%
-63.61+1.76%
-62.50—
Access this data via the Eulerpool API
Get Free API Key

Optiscan Imaging Stock analysis

What does Optiscan Imaging do? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optiscan Imaging stock

Forward P/E Ratio of Optiscan Imaging is -14.06 in 2026.

Forward P/E Ratio of Optiscan Imaging changed from -14.64 to -14.06, representing a -3.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Optiscan Imaging since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Optiscan Imaging with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Optiscan Imaging

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Optiscan Imaging